Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Cell therapy for cardiovascular disease: what cells, what diseases and for whom?

Nature Clinical Practice Cardiovascular Medicine volume 2, pages 37–43 (2005)Cite this article

Abstract

Experimental and human data suggesting progenitor cells possess the capacity to regenerate tissue and augment repair in injured organs has generated widespread interest in the basic research and clinical communities. Nowhere have these findings been more tantalizing than in human cardiovascular disease, in which vasculogenesis and myocardial regeneration logically and understandably remain as attractive therapeutic targets. Burgeoning experimental evidence attests to the proangiogenic, vasculogenic and tissue reparative capabilities of a broad range of progenitor cells derived from the bone marrow, circulation and a number of other tissues in vivo. Studies demonstrating the most apparent therapeutic success are those implicated in revascularization and repair of acute or chronically ischemic tissues in the heart and the peripheral vascular system. Numerous small clinical trials have yielded promising preliminary results without clear evidence of a superiority for a specific cell type or clinical disease entity as the most suitable target for cell therapy. This review will evaluate the scientific rationale for use of a specific cell or cells, the cardiovascular disease states most appropriate for targeted cell therapy, and the patient-specific barriers to therapeutic success, including emerging hurdles such as cardiovascular risk factors and comorbidities in eligible subjects.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Get just this article for as long as you need it

$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

References

  1. Kuehnle I and Goodell MA (2002) The therapeutic potential of stem cells from adults. BMJ 325: 372–376

    Article  Google Scholar 

  2. Wagers AJ et al. (2002) Little evidence for developmental plasticity of adult hematopoietic stem cells. Science 297: 2256–2259

    Article  CAS  Google Scholar 

  3. Pittenger MF et al. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284: 143–147

    Article  CAS  Google Scholar 

  4. Zuk PA et al. (2002) Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13: 4279–4295

    Article  CAS  Google Scholar 

  5. Beltrami AP et al. (2003) Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114: 763–776

    Article  CAS  Google Scholar 

  6. Menasche P (2004) Cellular transplantation: hurdles remaining before widespread clinical use. Curr Opin Cardiol 19: 154–161

    Article  Google Scholar 

  7. Taylor DA et al. (1998) Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med 4: 929–933

    Article  CAS  Google Scholar 

  8. Pagani FD et al. (2003) Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation. J Am Coll Cardiol 41: 879–888

    Article  Google Scholar 

  9. Menasche P et al. (2003) Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 41: 1078–1083

    Article  Google Scholar 

  10. Wollert KC et al. (2004) Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364: 141–148

    Article  Google Scholar 

  11. Assmus B et al. (2002) Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation 106: 3009–3017

    Article  Google Scholar 

  12. Orlic D et al. (2001) Bone marrow cells regenerate infarcted myocardium. Nature 410: 701–705

    Article  CAS  Google Scholar 

  13. Jackson KA et al. (2001) Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 107: 1395–1402

    Article  CAS  Google Scholar 

  14. Murry CE et al. (2004) Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428: 664–668

    Article  CAS  Google Scholar 

  15. Yoon Y-S et al. (2004) Unexpected Severe Calcification After Transplantation of Bone Marrow Cells in Acute Myocardial Infarction. Circulation 109: 3154–3157

    Article  Google Scholar 

  16. Toma C et al. (2002) Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105: 93–98

    Article  Google Scholar 

  17. Jiang Y et al. (2002) Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418: 41–49

    Article  CAS  Google Scholar 

  18. Makino S et al. (1999) Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 103: 697–705

    Article  CAS  Google Scholar 

  19. Mangi AA et al. (2003) Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 9: 1195–1201

    Article  CAS  Google Scholar 

  20. Asahara T et al. (1997) Isolation of Putative Progenitor Endothelial Cells for Angiogenesis. Science 275: 964–966

    Article  CAS  Google Scholar 

  21. Shi Q et al. (1998) Evidence for Circulating Bone Marrow-Derived Endothelial Cells. Blood 92: 362–367

    CAS  PubMed  Google Scholar 

  22. Harraz M et al. (2001) CD34− Blood-Derived Human Endothelial Cell Progenitors. Stem Cells 19: 304–312

    Article  CAS  Google Scholar 

  23. Rehman et al. (2003) Peripheral Blood “Endothelial Progenitor Cells” Are Derived From Monocyte/Macrophages and Secrete Angiogenic Growth Factors. Circulation 107: 1164–1169

    Article  Google Scholar 

  24. Badorff C et al. (2003) Transdifferentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes. Circulation 107: 1024–1032

    Article  Google Scholar 

  25. Madeddu P et al. (2004) Transplantation of low dose CD34+Kdr+ cells promotes vascular and muscular regeneration in ischemic limbs. FASEB J 18: 1737–1739 [doi: 10.1096/fj.04-2192fje]

    Article  CAS  Google Scholar 

  26. Nowak G et al. (2004) Expression of Vascular Endothelial Growth Factor Receptor-2 or Tie-2 on Peripheral Blood Cells Defines Functionally Competent Cell Populations Capable of Reendothelialization. Circulation [doi:10.1161/01.CIR.0000143626.16576.51]

  27. Rehman J et al. (2004) Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 109: 1292–1298

    Article  Google Scholar 

  28. Majka SM et al. (2003) Distinct progenitor populations in skeletal muscle are bone marrow derived and exhibit different cell fates during vascular regeneration. J Clin Invest 111: 71–79

    Article  CAS  Google Scholar 

  29. Agbulut O et al. (2004) Comparison of human skeletal myoblasts and bone marrow-derived CD133+ progenitors for the repair of infarcted myocardium. J Am Coll Cardiol 44: 458–463

    Article  CAS  Google Scholar 

  30. Caplice NM et al. (2003) Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation. Proc Natl Acad Sci U S A 100: 4754–4759

    Article  CAS  Google Scholar 

  31. Galinanes M et al. (2004) Autotransplantation of unmanipulated bone marrow into scarred myocardium is safe and enhances cardiac function in humans. Cell Transplant 13: 7–13

    Article  Google Scholar 

  32. Tse HF et al. (2003) Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet 361: 47–49

    Article  Google Scholar 

  33. Perin EC et al. (2003) Transendocardial, Autologous Bone Marrow Cell Transplantation for Severe, Chronic Ischemic Heart Failure. Circulation 107: 2294–2302

    Article  Google Scholar 

  34. Strauer BE et al. (2002) Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106: 1913–1918

    Article  Google Scholar 

  35. Britten MB et al. (2003) Infarct Remodeling After Intracoronary Progenitor Cell Treatment in Patients With Acute Myocardial Infarction (TOPCARE-AMI): Mechanistic Insights From Serial Contrast-Enhanced Magnetic Resonance Imaging. Circulation 108: 2212–2218

    Article  CAS  Google Scholar 

  36. Schachinger V et al. (2004) Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: Final one-year results of the TOPCARE-AMI Trial. J Am Coll Cardiol 44: 1690–1699

    Article  Google Scholar 

  37. Fernandez-Aviles F et al. (2004) Experimental and Clinical Regenerative Capability of Human Bone Marrow Cells After Myocardial Infarction. Circ Res 95: 742–748

    Article  CAS  Google Scholar 

  38. Hamano K et al. (2001) Local implantation of autologous bone marrow cells for therapeutic angiogenesis in patients with ischemic heart disease: clinical trial and preliminary results. Jpn Circ J 65: 845–847

    Article  CAS  Google Scholar 

  39. Fuchs S et al. (2003) Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease: A feasibility study. J Am Coll Cardiol 41: 1721–1724

    Article  Google Scholar 

  40. Pouly J et al. (2004) Does the Functional Efficacy of Skeletal Myoblast Transplantation Extend to Nonischemic Cardiomyopathy? Circulation 110: 1626–1631

    Article  Google Scholar 

  41. Tateishi-Yuyama E et al. (2002) Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 360: 427–435

    Article  Google Scholar 

  42. Hill JM et al. (2003) Circulating Endothelial Progenitor Cells, Vascular Function, and Cardiovascular Risk. N Engl J Med 348: 593–600

    Article  Google Scholar 

  43. Rauscher FM et al. (2003) Aging, Progenitor Cell Exhaustion, and Atherosclerosis. Circulation 108: 457–463

    Article  Google Scholar 

  44. Tepper OM et al. (2002) Human Endothelial Progenitor Cells From Type II Diabetics Exhibit Impaired Proliferation, Adhesion, and Incorporation Into Vascular Structures. Circulation 106: 2781–2786

    Article  Google Scholar 

  45. Heeschen C et al. (2004) Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 109: 1615–1622

    Article  Google Scholar 

  46. Kang HJ et al. (2004) Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet 363: 751–756

    Article  CAS  Google Scholar 

  47. Singh SK et al. (2003) Identification of a Cancer Stem Cell in Human Brain Tumors. Cancer Res 63: 5821–5828

    CAS  PubMed  Google Scholar 

  48. Vulliet PR et al. (2004) Intracoronary arterial injection of mesenchymal stromal cells and microinfarction in dogs. Lancet 363: 783–784

    Article  Google Scholar 

  49. Laufs U et al. (2004) Physical Training Increases Endothelial Progenitor Cells, Inhibits Neointima Formation, and Enhances Angiogenesis. Circulation 109: 220–226

    Article  CAS  Google Scholar 

  50. Vasa M et al. (2001) Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 103: 2885–2890

    Article  CAS  Google Scholar 

Download references

Author information

Author notes

  1. Noel M Caplice, Bernard J Gersh and Jorge R Alegria: N Caplice is a clinical investigator and consultant cardiologist, BJ Gersh is a Professor of Medicine and JR Alegria is a Fellow in Cardiovascular Diseases

Authors and Affiliations

  1. Division of Cardiovascular Diseases, Molecular Medicine Program, Mayo College of Medicine, Rochester, MN, USA

    Noel M Caplice, Bernard J Gersh & Jorge R Alegria

Authors
  1. Noel M Caplice
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bernard J Gersh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jorge R Alegria
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Noel M Caplice.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Caplice, N., Gersh, B. & Alegria, J. Cell therapy for cardiovascular disease: what cells, what diseases and for whom?. Nat Rev Cardiol 2, 37–43 (2005). https://doi.org/10.1038/ncpcardio0073

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpcardio0073

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing